Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
Pett SL, Spyer M, Haddow LJ, Nhema R, Benjamin LA, Najjuka G, Bilima S, Daud I, Musoro G, Kitabalwa J, Selemani G, Kandie S, Cornelius KM, Katemba C, Berkley JA, Hassan AS, Kityo C, Hakim J, Heyderman RS, Gibb DM, Walker AS; REALITY trial team.
Pett SL, et al. Among authors: benjamin la.
AIDS. 2021 Mar 15;35(4):585-594. doi: 10.1097/QAD.0000000000002781.
AIDS. 2021.
PMID: 33306556
Free PMC article.
Clinical Trial.